ImmunityBio (IBRX) Earnings Date & Reports

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IBRX is expected to report earnings to rise 56.67% to -23 cents per share on August 09

Q2'23

Est.

$-0.23

Q1'25

Missed

by $0.02

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.04

Q2'24

Est.

$-0.20

The last earnings report on May 12 showed earnings per share of -15 cents, missing the estimate of -12 cents. With 5.15M shares outstanding, the current market capitalization sits at 2.34B.

View a ticker or compare two or three

Compare

IBRX